fda glp-1 compounding crackdown september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA warns telehealth providers over

You feel it: fatigue, brain fog, skin breakouts, even sensitivity to alcohol or stress

"This agreement further underscores our commitment to advancing breakthrough therapies for patients suffering from chronic conditions with significant unmet medical needs." In addition to its strong presence in oncology and vaccines, Merck has been expanding its diabetes and obesity pipeline, recognizing the increasing global burden of these diseases

Within that, a new subsector has emerged: telehealth-delivered GLP-1 care, an estimated $6.9 billion market thats swelling as digital platforms turn prescription drugs into subscription products

Mohammadi Vadoud, and H

Bech EM, Martos-Maldonado MC, Wismann P, et al